Revolution Medicines, Inc. · NASDAQ:RVMD

Kelsey Stephen Michael sold 92,531 Revolution Medicines, Inc. shares (Form 4)

Traded Sep 11, 2026 · Filed Sep 15, 2026

On Sep 11, 2026, Kelsey Stephen Michael (See Remarks) sold 92,531 Revolution Medicines, Inc. shares at an average US$202.36 for US$18.7M under a trading plan, leaving 291,876 shares. Filed Sep 15, 2026 (Form 4).

Sold
92,531 shares
Price
US$202.36 average (US$198.55 to US$205.81)
Value
US$18.7M
Holding after
291,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 11, 2026Common StockOption exercise52,500US$42.45344,376Direct
Sep 11, 2026Common StockOption exercise40,031US$40.74384,407Direct
Sep 11, 2026Common StockSale800US$198.55383,607Direct
Sep 11, 2026Common StockSale11,833US$200.11371,774Direct
Sep 11, 2026Common StockSale13,368US$200.78358,406Direct
Sep 11, 2026Common StockSale21,447US$201.75336,959Direct
Sep 11, 2026Common StockSale18,869US$203.06318,090Direct
Sep 11, 2026Common StockSale17,949US$203.87300,141Direct
Sep 11, 2026Common StockSale4,995US$204.84295,146Direct
Sep 11, 2026Common StockSale3,270US$205.81291,876Direct

Source

View original at SEC

Related